Genetic susceptibility to preeclampsia: Roles of cytosine-to-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine β-synthase, and factor V Leiden mutation

American Journal of Obstetrics and Gynecology

Volumn 184, Issue 6, 2001, Pages 1211-1217

  Kim, Young Ju ^a,b,c,d   Williamson, Roger A ^a   Murray, Jeffrey C ^b   Andrews, Janet ^a   Pietscher, Jorie J ^b   Peraud, Peter J ^b   Merrill, David C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Wake Forest University ^*  (United States)

^d Ewha Womans University   (South Korea)

Author keywords

Cystathione synthase; Factor V Leiden; HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome; Methylenetetrahydrofolate reductase; Preeclampsia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; CYSTATHIONINE BETA SYNTHASE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HELLP SYNDROME; HETEROZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUTATION RATE; NUCLEIC ACID BASE SUBSTITUTION; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; THROMBOSIS; VASCULAR DISEASE;

EID: 0035340294     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2001.110411     Document Type: Article

References (25)

1. Morgan T, Ward K. New insights into the genetics of preeclampsia. Semin Perinatol 1999;23:14-23.
2. Dizon-Townson DS, Nelson LM, Easton K, Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996;175:902-5.
3. Dekker G, de Vries JI, Deelitzsch PM, Huijgens PC, von Blomberg BM, Jacobs C. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995;173: 1042-8.
4. O'Shaughnessy KM, Fu B, Ferraro F, Lewis I, Downing S, Morris NH. Factor V Leiden and thermolabile methylene tetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort. Hypertension 1999;33:1338-41.
5. McCully KS. Homocysteine and vascular disease. Nat Med 1996;2:386-9.
6. Goddijn-Wessel TA, Wouters MG, van de Molen EF, Spuijbroek MD, Steegers-Theunissen RP, Blom HJ, et al. Hyperhomocysteinemia: A risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol 1996;66:23-9.
7. Steegers-Theunissen RP, Boers GH, Trijbels JM, Eskers TK. Hyperhomocysteinaemia and recurrent abortion or abruptio placentae. Lancet 1992;339:1122-3.
8. Rajkovic A, Catalano PM, Malinow MR. Elevated homocysteine levels with preeclampsia. Obstet Gynecol 1997;90:168-71.
9. Kluijtmans LA, van den Heuvel LP, Boers GH, Frosst P, Stevens EM, van Oost BA, et al. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996;58:35-41.
10. Sebastio G, Sperandeo MP, Panico M, de Franchis R, Kraus JP, Andria G. The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations. Am J Hum Genet 1995;56:1324-33.
11. Tsai MY, Bignell M, Schwichtenberg K, Hanson NQ. High prevalence of a mutation in the cystathionine β-synthase gene. Am J Hum Genet 1996;59:1262-7.
12. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369: 64-7.
13. Kirschbaum N, Foster P. The polymerase chain reaction with sequence specific primers for the detection of the factor V mutation associated with activated protein C resistance. Thromb Haemost 1995;74:874-8.
14. Dahlbäck B. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene. Haemostasis 1994;24:139-51.
15. Trembath D, Sherbondy AL, Vandyke DC, Shaw M, Todoroff K, Lammer EJ, Analysis of select folate pathway genes, PAX3, and human T in a Midwestern neural tube defect population. Teratology 1999;59:331-41.
16. Laivuori H, Kaaja R, Turpeinen U, Viinikka L, Ylikorkala O. Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia. Obstet Gynecol 1999;93:489-93.
17. Powers RW, Evans RW, Majors AK, Ojimba JI, Ness RB, Crombleholme WR, et al. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 1998;179:1605-11.
18. Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, et al. Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 1997;77:1052-4.
19. Sohda S, Arinami T, Hamada H, Yamada N, Hamahuchi H, Kubo T. Methylenetetrahydrofolate reductase polymorphism and preeclampsia. J Med Genet 1997;34:525-6.
20. Powers RW, Minich LA, Lykins DL, Ness RB, Crombleholme WR, Roberts JM. Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia. J Soc Gynecol Investig 1999;6:74-9.
21. 6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. Am J Obstet Gynecol 1998;179:135-9.
22. Mimuro S, Lahoud R, Beutler L, Trudinger B. Changes of resistance to activated protein C in the course of pregnancy and prevalence of factor V mutation. Aust N Z J Obstet Gynaecol 1999;38:200-4.
23. Nagy B, Toth T, Rigo J, Karadi I, Romics L, Papp Z. Detection of factor V Leiden mutation in severe preeclamptic Hungarian women. Clin Genet 1998;53:479-81.
24. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy [published erratum appears in N Engl J Med 1999;341:384]. N Engl J Med 1999;340:9-13.
25. De Groot CJ, Bloemenkamp KW, Duvekot EJ, Helmerhorst FM, Bertina RM, Van Der Meer F, et al. Preeclampsia and genetic risk factors for thrombosis: A case-control study. Am J Obstet Gynecol 1999;181:975-80.